148 related articles for article (PubMed ID: 11220758)
1. Molecular typing of Trichomonas vaginalis isolates by HSP70 restriction fragment length polymorphism.
Stiles JK; Shah PH; Xue L; Meade JC; Lushbaugh WB; Cleary JD; Finley RW
Am J Trop Med Hyg; 2000 Apr; 62(4):441-5. PubMed ID: 11220758
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of Egyptian Trichomonas vaginalis clinical isolates by HSP70 restriction fragment length polymorphism.
Hussien EM; El-Sayed HZ; El-Moamly AA; Helmy MM; Shaban MM
J Egypt Soc Parasitol; 2005 Aug; 35(2):699-710. PubMed ID: 16083077
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes.
Meade JC; de Mestral J; Stiles JK; Secor WE; Finley RW; Cleary JD; Lushbaugh WB
Am J Trop Med Hyg; 2009 Feb; 80(2):245-51. PubMed ID: 19190222
[TBL] [Abstract][Full Text] [Related]
4. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-RFLP in Iran.
Momeni Z; Sadraei J; Kazemi B; Dalimi A
Exp Parasitol; 2015 Dec; 159():259-63. PubMed ID: 26542260
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-restriction fragment length polymorphism.
Crucitti T; Abdellati S; Van Dyck E; Buvé A
Clin Microbiol Infect; 2008 Sep; 14(9):844-52. PubMed ID: 18844685
[TBL] [Abstract][Full Text] [Related]
6. Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T. vaginalis viruses.
Masha SC; Cools P; Crucitti T; Sanders EJ; Vaneechoutte M
Parasit Vectors; 2017 Oct; 10(1):537. PubMed ID: 29084570
[TBL] [Abstract][Full Text] [Related]
7. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
[TBL] [Abstract][Full Text] [Related]
9. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
10. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
Mabaso N; Abbai N
Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
[TBL] [Abstract][Full Text] [Related]
11. Genetic Diversity of Trichomonas Vaginalis Clinical Isolates According to Restriction Fragment Length Polymorphism Analysis of the 60-kDa Proteinase Gene.
Hernández H; Fraga J; Marcet R; Alba A; Figueredo M; Alfonso Y; Rojas L; Sarracent J
Acta Parasitol; 2019 Jun; 64(2):300-307. PubMed ID: 31165993
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and genetic diversity of Trichomonas vaginalis clinical isolates in a targeted population in Xinxiang City, Henan Province, China.
Zhang Z; Kang L; Wang W; Zhao X; Li Y; Xie Q; Wang S; He T; Li H; Xiao T; Chen Y; Zuo S; Kong L; Li P; Li X
Parasit Vectors; 2018 Mar; 11(1):124. PubMed ID: 29499747
[TBL] [Abstract][Full Text] [Related]
13. Trichomonas vaginalis: intrastrain polymorphisms within the ribosomal intergenic spacer do not correlate with clinical presentation.
Simões-Barbosa A; Lobo TT; Xavier J; Carvalho SE; Leornadecz E
Exp Parasitol; 2005 Jun; 110(2):108-13. PubMed ID: 15888292
[TBL] [Abstract][Full Text] [Related]
14. Determination of Trichomonas vaginalis Genotypes Using PCR-Restriction Fragment Length Polymorphism (RFLP).
Demirağ S; Malatyalı E; Ertuğ S; Ertabaklar H
Turkiye Parazitol Derg; 2017 Dec; 41(4):188-191. PubMed ID: 29318987
[TBL] [Abstract][Full Text] [Related]
15. Genetic relatedness of Trichomonas vaginalis reference and clinical isolates.
Cornelius DC; Mena L; Lushbaugh WB; Meade JC
Am J Trop Med Hyg; 2010 Dec; 83(6):1283-6. PubMed ID: 21118935
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
Meri T; Jokiranta TS; Suhonen L; Meri S
J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
[TBL] [Abstract][Full Text] [Related]
17. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
18. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
19. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
[TBL] [Abstract][Full Text] [Related]
20. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
